Associated Papers
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM et al.
Cancer Research Communications, 2024
38282550 (PubMed )
Supplement: crc-23-0312-s02.xlsx › Fig3B_EC_data
Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR.
Lim Y et al.
Scientific Reports, 2021
34381078 (PubMed )
Supplement: 41598_2021_95345_MOESM5_ESM.xlsx › Suppl._Table_4
Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs.
Gad MM et al.
Familial Cancer, 2020
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
Karlsson A et al.
Oncotarget, 2015
26124082 (PubMed )
Supplement: oncotarget-06-22028-s003.xlsx › Variants_in_Lund_cohort
Genetic testing for inherited susceptibility to colorectal cancer: part I. Adenomatous polyposis coli (APC) gene mutations.
Unknown Author
Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel, 1998
[K-ras gene mutations in adenomas from familial adenomatous polyposis].
Ohki S et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 1996
DNA alterations in cells from hereditary non-polyposis colorectal cancer patients.
Wu C et al.
Oncogene, 1994
Select a paper to view details